02/11/2026 | News release | Distributed by Public on 02/11/2026 09:48
Applications Due March 9, 2026
This award supports academic researchers advancing promising rare-disease discoveries toward clinical application. The program provides funding plus hands-on therapeutics development support to accelerate preclinical projects. Areas of interest include rare neurological, developmental, metabolic disorders, rare cancers, and other high-unmet-need genetic diseases. All therapeutic modalities are considered.
Award benefits:
Learn more: OxfordHarrington.org/Award
APPLY: Create an account at the Harrington grant system
Questions? [email protected].
Informational Webinar and Q&A session: February 17, 11:00 am - 12:00 pm ET. REGISTER HERE.
UTRF is happy to help with any questions or discussions on how to proceed with this grant opportunity. Contact James Parrett, JD, PharmD, UT Research Foundation, at [email protected].